Introduction
The hematopoietic system achieves the goal of continuous replacement of blood cells through self-renewal of pluripotent hematopoietic stem cells and their subsequent commitment to progenitor and precursor cells of gradually more restricted potential. Lineage specific transcription factors play essential roles in regulating hematopoietic development, activating gene programs and at the same time exerting inhibitory effects on alternate lineage programs establishing delicate balances essential to maintain normal hemopoiesis and avoiding malignancy.
1
The transcription factor Gfi1b is expressed in hematopoietic stem cells, common myeloid progenitors and in megakaryocyte/erythroid progenitors and lineages. There is also evidence of moderate levels of expression in immature B-cells, a subset of early T-cell precursors and peripheral blood granulocytes and monocytes. 2, 3 During erythroid differentiation Gfi1b is up-regulated in early erythroblast stages and decreases with terminal differentiation. 2, 4, 5 Its role in erythropoiesis is crucial for expansion and differentiation of erythroid progenitors. 4, 5 Knockout mice have demonstrated that this gene is required for development of both erythroid and megakaryocytic lineages. 6 Additionally, Gfi1b expression has been recently found increased in leukemia patients and cell lines. 7, 8 The last work also showed a reduction in proliferation of the HEL erythroleukemia cell line after down regulation of Gfi1b using siRNA, further supporting its role in this malignancy.
8
Gfi1b has six C-terminal C2H2 zinc-fingers that bind DNA in a sequence specific manner at sites containing an AATC core sequence (consensus recognition sequence TAAATCAC A /TGC A /T) and an N-terminal SNAG transcriptional repression domain.
9-11 Gfi1b repression activity is achieved by recruiting lysine specific demethylase 1 (LSD1 or KDM1), REST corepressor (CoREST) and HDACs 1 and 2 to DNA. 12 At the DNA level Gfi1b represses cyclin-dependent kinase inhibitor p21 WAF1 , 11 proto-oncoges myc and myb in association with GATA1, 13 tumor suppressor genes Socs1 and Socs2, 14 the antiapoptotic gene Bcl-xL, 15 the proto-oncogene Gfi11 6, 17 and Gfi1b itself. 18 At the protein level Gfi1b interacts with transcription factors SCL, 19, 20 E2A,
20

GATA1
13 and corepressors ETO 21 and ETO2.
19,20
All these facts indicate that correct Gfi1b expression is important to achieve normal erythroid and megakaryocytic differentiation. Therefore, it is important to understand how Gfi1b expression is regulated, but the only regulatory element identified in erythroid and megakaryocytic cells is the promoter. 12, 17, 18, 22, 23 To gain further insight into Gfi1b regulation, we have used multiple species sequence comparison to identify distant cis-acting regulatory elements at the Gfi1b locus. Some of these sites localize with open chromatin conformation areas and show close spatial association with the promoter. We confirmed that transcription factors GATA1, SCL, ETO2 and Gfi1b itself, bind to the Gfi1b promoter, 17, 18, 22, 23 but also demonstrate that they bind to the CNEs together with other factors, including NF-E2, E2A, Ldb1, LMO2, Pu.1 and c-Myb. Chromatin modifications and cofactor binding at different stages of erythropoiesis and megakaryopoiesis suggest that those new regulatory sequences share with the promoter a dual positive and negative regulatory function revealing a complex and delicate equilibrium required to control Gfi1b level and, ultimately, to achieve normal cell differentiation.
Design and Methods
Identification of conserved noncoding elements (CNEs)
Preliminary alignments were assembled with ECR browser (http://ecrbrowser.dcode.org/).
24
Genomic sequences spanning the Gfi1b locus were obtained from NCBI (http://www.ncbi.nlm.nih.gov/) and Ensembl (http://www.ensembl.org/index.htlm) databases. Subsequent alignments were performed with MacVector software (Accelrys, Cary, NC, USA). Transcription factor binding sites were identified with R-VISTA (http://rvista.dcode.org/) 25 and MacVector.
Cell culture L929 fibroblasts, L8057 megakaryocytic and K562 and MEL 585 erytroid cells were grown in RPMI 1640 medium (Sigma, St Louis, MO, USA) with 50 U/mL penicillin G (Gibco BRL, Rockville, MD, USA), 50 mg/mL streptomycin (Gibco BRL), 2 mM L-glutamine (Gibco BRL) and 10% (v/v) fetal calf serum (Gibco BRL). MEL cells were induced to differentiate with N,N´-Hexamethylenebisacetamide (HMBA) (Sigma) 5 mM and and 10% (v/v) fetal calf serum (Biosera, East Sussex, UK) for 3 days.26 L8057 were induced with 50 nM 12-O-tetradecanoylphorbol 13-acetate (TPA) (Sigma) for 3 days.
27
Purification of mouse primary erythroid cells
Primary erythroid cells were isolated as described. 28 Briefly, C57BL/6 mice were injected intraperitonally with phenylhydrazine (Sigma), 0.04 mg/g body weight, three times at 12-hour intervals. TER119 + cells were isolated at day 6 by labeling splenocytes with biotin conjugated rat anti-mouse TER119 antibody (BD, Franklin Lakes, NJ, USA) and incubated with antibiotin microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany). The positive fraction was obtained on AUTOMACS (Miltenyi Biotec). Purity was assessed by flow cytometry, over 80% TER119 + cells were obtained.
RNA isolation and quantitative real-time PCR expression study RNA was extracted with Tri reagent (Sigma). Ribosomal RNA integrity and concentration was checked in a formaldehyde agarose gel. cDNA was obtained with MuLV reverse transcriptase (Applied Biosystems, Foster City, CA, USA) and primer random (Roche, Basel, Switzerland). Gfi1b cDNA was analyzed by real-time PCR in a in a 25 mL reaction containing Taqman Universal PCR Master Mix (Applied Biosystems) and TaqMan(R) Gene Expression Assay Mm01336944_m1 mix with FAM-NFQ probe between Gfi1b exons 1 and 2 (Gene Expression Assays, Applied Biosystems) following manufacturer recommendations. Gfi1b expression was calculated for each cell type relative to Taqman(R) Gene Expression Assays Mm00839493_m1 DNA-directed RNA polymerase II polypeptide A and normalized with FDCP-Mix results using the -DDCt method.
29
Western blot
Protein extract was prepared in lysis buffer (60 mM TRIS, 10% Glycerol, 2% SDS) and sonicated, concentration was assessed by DC protein Assay (Bio Rad, Hercules, CA), 30 mg of protein were separated by SDS-PAGE on a NuPAGE 3-8% Tris-Acetate gel (Invitrogen, Carlsbad, CA), transferred to an Immobilon-PSQ membrane (Millipore, Billerica, MA), labeled with Gfi1b antibody and an anti-goat HRP-conjugated secondary antibody (sc-2020, Santa Cruz Biotechnology, Santa Cruz, CA) and detected with ECL plus (GE Health care).
Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE)
FAIRE procedure has been previously described in detail. 30 Real time PCR analysis was performed with primers and Taqman probes shown in Online Supplementary Table 1 in an ABI Prism 7000 Sequence Detection System. FAIRE samples data was normalized with input material in which the cross-link was reverted at 65ºC for 4 hours. Enrichment of each amplicon was calculated relative to the result at an area previously found insensitive to DNase1 (c16orf8 or DIST gene) (Online supplementary Table 1) , 31 using the -∆∆ Ct method.
29
DNase1 hipersensitivity
DNase1 HSs were analyzed as before. 26 DNA was isolated with phenol/chloroform, digested with BamHI or HindIII restriction enzymes and analyzed by Southern blot using a single-copy probe obtained by PCR (forward primer 5´-GAAAGCTCCTGCTGTGTTTCCC-3á nd reverse primer 5´-GGGAGGCAAGGTTCA-GAATTTC-3´).
Chromatin immunoprecipitation (ChIP) assay and real-time PCR analysis
ChIPs were performed according to the Upstate protocol, as described previously.
31 Cells (1x10 7 per experiment) were fixed with 0.4% formaldehyde for 10 minutes. at room temperature for transcription factors and 1% formaldehyde 10 minutes at 37 ºC in case of cofactors. Chromatin was sonicated to a size of less than 500 bp. Immunoprecipitations were performed, after an overnight incubation with the appropriate antibody, with protein A agarose (Upstate, Temecula, CA), or with protein G agarose (Roche) according to the antibody. A sample containing no antibody was used as a negative control.
Immunoprecipitated DNA was analyzed by quantitative real time PCR. Primers and 5'FAM-3'TAMRA Taqman probes were designed by Primer Express software. All primers and probes were validated over a serial dilution of genomic DNA. For a given target sequence, the amount of product precipitated by a specific antibody was determined relative to the amount of non immunoprecipitated (input) DNA and these results were normalized to a control sequence in the 18S ribosomal RNA gene (18S rRNA control kit, Eurogentec, Liege, Belgium) for human cells and GAP-DH in mouse studies. 31 Primers and probes from a globin locus controls have been published before for both human32 and mouse. 31 Mouse Gfi1b locus and human Gfi1b and bActin CpG island control are shown in Online Supplementary Tables 1 and 2 , respectively. Mouse bActin control has been published. 31 
Chromosome Conformation Capture (3C)
This technique was performed as described.
33,34
Briefly, 1x10 7 cells per experiment were fixed with 2% formaldehyde, lysed in 10 mM TRIS pH 8,10 mM NaCl, 0.2% NP-40 with complete protease inhibitors (Roche), digested with 400 U DpnII (NE biolabs, Ipswich, MA, USA) and ligated with T4 ligase (Fermentas, Burlington, Ontario, Canada). Forward primer and Taqman probe at the restriction fragment including Gfi1b promoter and primers at other restriction fragments are shown in supplementary Table 3 . Real time PCR data were normalized with the results of an amplicon without DpnII restriction sites at a-globin HS-31 (Online supplementary  Table 3 ) 31 and corrected with the analysis of Ercc3 locus, these last primers and probe were Dr Douglas Vernimmen generous gift.
34
Immunofluorescence
The study was performed as before. 31 The images were obtained using an Olympus BX 51 microscope with a confocal BioRad Radiance 2000 system. Fluorescence intensities were measured with Metamorph software (Molecular Devices, Sunny Vale, CA, USA). 31 Images were imported into Photoshop and the only manipulation performed was contrast stretch.
Antibodies
We used antibodies against Pol II (N-20, sc-899, Santa Cruz), E47 (N-649 X, sc-763 X, Santa Cruz, CA, USA), LMO2 (AF2726, R&D systems, McKinley Place NE, MN, USA), CLIM-2 (Ldb1) (N18, sc-11198, Santa Cruz), NF-E2 p45 (C-19, sc-291, Santa Cruz), NF-E2 p18 (C-16, sc-477, Santa Cruz), ETO-2 (G-20, sc-9741, Santa Cruz, CA, USA), c-Myb (H-141, sc-7874, Santa Cruz), PU.1 (T-21, sc-352, Santa Cruz), dimethyl histone H3 lysine 4 (07-030, Upstate), acetyl Histone H4 (06-866, Upstate), acetyl Histone H3 (06-599, Upstate), CoREST (ab24166, Abcam, Cambridge, UK), KDM1/LSD1 (ab17721, Abcam), CoREST (07-455, Upstate), the SCL antibody was a gift from Katherine Porcher. Together with specific antibodies for mouse GATA1 (N-6, sc-265, Santa Cruz) and Gfi1b (D-19 X, sc-8559 X, Santa Cruz, CA, USA) and human GATA1 (C-20 X, sc-1233 X, Santa Cruz, CA, USA) and human Gfi1b (B-7 X, sc-28356 X, Santa Cruz, CA, USA). 
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Results
Multispecies conserved regions downstream Gfi1b gene contain erythroid and megakaryocytic transcription factor binding sequences
Cis-acting regulatory elements are frequently identified as multispecies conserved noncoding elements (CNEs). To study Gfi1b gene regulation we first analyzed, using the ECR browser and McVector software, sequence conservation over 86 kb of human sequence between the TSC1 (tuberous sclerosis 1) and GTF3C5 (general transcription factor IIIC, polypeptide 5) genes, that flank Gfi1b ( Figure 1A and data not shown). We identified one CNE within the first intron and three downstream of the Gfi1b gene that contain several highly conserved erythroid/megakaryocytic transcription factor binding sites ( Figure Figures 1-3) . CNEs +1 and +3 have been conserved from human to birds, whilst CNE+2 is strongly conserved down to marsupials. The intronic area (CNEi) is well conserved in eutherian mammals, but only partly conserved in marsupials.
© F e r r a t a S t o r t i F o u n d a t i o n © F e r r a t a S t o r t i F o u n d a t i o n
The downstream CNEs, +1, +2 and +3, included at least one fully conserved canonical GATA binding site ( 35 together with other potential GATA recognition sites. [36] [37] [38] [39] At least one E-box, SCL/E2A heterodimer binding site, is present in most species at all three regions. In addition, a conserved NF-E2 binding site 40 is located at the most downstream CNE. We did not identify any Gfi1/Gfi1b consensus binding sequence, although the core AATC sequence has been frequently conserved ( Figure 1B , and Online supplementary Figures 1-2) .
Other recognition sequences for transcription factors involved in hematopoiesis are also present in multiple species at those CNEs. One Myb consensus core DNAbinding site has been highly conserved in both CNE+1 and +3, the first of them matching the extended consensus Western blot demonstrating the decrease in Gfi1b protein level with erythroid differentiation, the same amount of total protein is loaded in duplicate for each cell type.
Online supplementary Figure 2) . Finally, multiple conserved Ets transcription factors binding motifs42 can be identified in of all these regions ( Figure 1B , and Online supplementary Figures 1-2 ) . The CNEi has 6 potential GATA binding sites, one of which shows a perfect match with the classical GATA binding sequence in most species. There is also a potential Myb binding site and several AATC and Ets binding motifs (Online supplementary Figure 3) .
This data is suggestive that these CNEs represent potential cis-elements of Gfi1b.
3´CNEs associate with open chromatin regions and recruit RNA polymerase II
We have previously demonstrated that mouse erythropoiesis can be recapitulated with primary cells and cell lines that can be used for ChIP analysis.
31 Thus, we followed this strategy to study Gfi1b regulation through the differentiation process with cells representing different stages of erythroid and megakaryocytic differentiation. L929 fibroblast cell line was used as a source of differentiated murine non-hematopoietic cells.
We first studied Gfi1b expression in those cells by real-time PCR. Gfi1b RNA was detected in L929 cells at the limit of the sensitivity of the technique, in the order of 105 times less than in FDCP-Mix hematopoietic progenitors. Erythroid and megakaryocytic cells expressed higher levels of Gfi1b, but decreasing with cell differentiation ( Figure 2A ). We confirmed this pattern of expression in erythroid cells at the protein level by western blot ( Figure 2B) .
Active chromatin at sites associated with transcription regulation adopts an open conformation. To assay this we used the recently developed technique FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements), 30 which enriches for nucleosome free DNA. Real time PCR analysis of the Gfi1b locus shows the promoter, CNE+1 and CNE+3 to be highly enriched in nucleosome free DNA relative to the genomic DNA in expressing MEL cells, but not in the control L929 cells ( Figure 2C ). We also confirmed the presence of specific DNase1 hypersensitive sites at CNE+1 and +3 (Online supplementary Figure 4) .
Next, we analyzed Pol II recruitment to the Gfi1b locus by chromatin immunoprecipitation assay (ChIP). We confirmed Pol II binding at both the Gfi1b promoter and the CNEi in all the erythroid cells, but in L929 cells Pol II was only enriched at the GTF3C5 control gene ( Figure 2D) . Consistent with the expression data, the level of Pol II binding reduced with erythroid differentiation. We also observed Poll II recruited to the 3´CNEs in erythroid cells, further suggesting that these areas have a regulatory role.
In summary, CNE+1 and +3 become nucleosome free in Gfi1b expressing cells and Poll II is recruited to these sites. This is consistent with the idea that these correspond to cis-regulatory elements of the Gfi1b gene.
GATA/SCL complex binds to Gfi1b downstream CNEs and the promoter, decreasing with erythroid differentiation
It is known that GATA1 binds at Gfi1b promoter in human erythroid K562 cells, where it has a positive regulatory function. 22 Given the conservation and number of potential GATA binding motifs at Gfi1b downstream CNEs, we first searched for GATA1 binding in vivo using ChIP. We confirmed GATA1 binding at the promoter and found a much higher enrichment of CNEs +1 and +3, together with a weak enrichment of CNE+2 ( Figure  2E ). The CNEi was very slightly enriched over the background level, as we confirmed in a detailed analysis (Online supplementary Figure 5 ). GTF3C5 and a-globin loci acted as negative and positive controls, respectively ( Figure 2E) .
The GATA1/SCL pentameric complex binds to DNA at closely spaced GATA and E-box binding motifs. Besides the canonical E-box/GATA (an E-box situated 8-10 nucleotides upstream of the GAT motif, 43 binding of this complex can also be mediated by variations of this, 44 or by GATA sites alone. 31 ,45 Therefore, we tested the binding of the remaining components of the pentameric complex, SCL, E2A, LMO2 and Ldb1, and we observed that they followed GATA1 with an almost identical profile ( Figure 3A -B and Online supplementary Figure 6 A-B). These factors were absent from the elements upstream Gfi1b gene and from the intronic areas.
Binding of the pentameric complex decreased with erythroid differentiation at Gfi1b locus, consistently with Pol II binding and Gfi1b expression.
In conclusion, this coordinate binding of known erythroid transcription factors to the CNEs and the promoter, and the strong link between the occupancy, the expression status and Pol II recruitment, deeply supports the idea that these elements, particularly +1 and +3, regulate the expression of Gfi1b in part via the previously described pentameric complex.
Transcription factor binding at preferential sites of Gfi1b Locus.
Besides GATA recognition sequences and E-boxes we observed other conserved potential binding sequences for hematopoietic transcription factors. These included NF-E2 at CNE+3, Myb recognition elements at CNEs+1, +3 and CNEi and multiple Ets-domain binding sites at all the CNEs. The Ets family member PU.1 has been shown to antagonize GATA1 transcriptional activity by binding to it when GATA1 is bound to DNA; 46 this factor is over-expressed in MEL cells, blocking erythroid differentiation. 47 ChIP analysis showed that both the hematopoieticrestricted 45 kDa (p45) and ubiquitous 18 kDa (p18) subunits of the NF-E2 transcription factor can be identified at CNE+3 (Figure 3C-D) . The dynamics of NF-E2 binding followed the pentameric complex, reducing with erythroid differentiation. In MEL cells, c-Myb binding was detected at CNE+1 (Online Supplementary Figure 6C ) and the Gfi1b promoter was highly enriched for PU.1 (Supplementary Figure 6D) .
This data suggests that CNE+1 and +3 have distinct roles in Gfi1b regulation and shows that PU.1 binding is promoter specific. 
© F e r r a t a S t o r t i F o u n d a t i o n © F e r r a t a S t o r t i F o u n d a t i o n
Epigenetic signals for gene activation correlate with pentameric complex binding
We assessed chromatin status by analyzing histone H4 acetylation (AcH4) and dimethylation of lysine 4 of histone H3 (H3diMeK4) which are both marks of gene activation. 48, 49 Both histone modifications had similar patterns, with high levels of AcH4 and H3diMeK4 at the Gfi1b gene, the 3´CNEs and to lower degree at the Gfi1b promoter. Unlike the decrease in transcription factor binding, chromatin changes remained similar or even increased with erythroid differentiation. Upstream of the Gfi1b promoter, chromatin modifications progressively reduced to background levels ( Figure 4 ). While this paper was under review Laurent B, et al published a human Gfi1b promoter study that also showed that this site is associated to active chromatin marks during erythroid differentiation in agreement with our data.
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Interestingly, the CNE with the highest level of AcH4 and H3diMeK4 in most erythroid cells is CNE+2, which showed the lowest binding of the pentameric complex.
In summary, chromatin modifications suggest that the downstream CNEs have a positive regulatory function and CNE+2 seems to have distinctive characteristics among the others.
Gfi1b binds to multiple sites in its own locus. CoREST and LSD1 are found at Gfi1b binding sites Gfi1b has been found at its own promoter and this could switch GATA1 effect from activation to repression.18 Therefore, we investigated Gfi1b binding to verify whether it has any further binding at its locus. In fact, Gfi1b binds not only at its promoter, but also at CNEi, +1 and +3 in MEL cells ( Figure 5A and Online supplementary Figure 5 ).
Corepressor ETO2 has been shown to interact with GATA/SCL pentameric complex, mainly at early stages of erythroid and megakaryocytic differentiation, turning its activity into repression. 19, 20, 23, 51 ETO2 recruitment at the Gfi1b promoter suggests that it may have a repressive activity at this locus.
23 Surprisingly, when we analyzed ETO2 by ChIP assay in our system, we detected ETO2 at CNE+1 and +3 in MEL cells, but there was no a clear enrichment of other Gfi1b binding areas in these cells or in terminally differentiated erythroblasts ( Figure 5B and Online supplementary Figure 5 ). Figure 2 . Note that E47 is not present at the intronic E-boxes (arrows), E2A E12 showed a similar pattern (data not shown). Both NF-E2 subunits showed binding at CNE+3; reduction in NFE2 binding at this site with erythroid differentiation contrast with its maintenance or increase at a-globin locus.
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The Gfi1b SNAG domain recruits LSD1 and CoREST, and this mediates its transcriptional repression activity.
12
We detected LSD1 and CoREST in vivo at the same sites and cells where we found Gfi1b (Figure 5C-D) . In TER119 + cells, both corepressors were mainly present at the promoter, but also remained at a low level at the downstream elements. We conclude that CNEi, +1 and +3 share with Gfi1b promoter both characteristics of gene activators as well as of negative regulators.
Distal regulatory elements bind the same complexes in the megakaryocytic lineage and human erythroid cells Many specific transcription factors are common to the erythroid and megakaryocytic lineages, including Gfi1b. Thus, we analyzed the binding pattern of Poll II, the pentameric complex, Gfi1b, LSD1 and CoREST in the megakaryocytic cell line L8057 induced to megakaryocytic differentiation with TPA. We observed an almost identical binding to the one described for erythroid cells (Online supplementary Figure 7) .
In the human cell line K562, which has some erythroid features, we confirmed GATA1 binding at the Gfi1b promoter together with Pol II (Online supplementary Figure 8 ). CNEs +1 and +3 were also highly enriched using GATA1 antibody. Again we detected a weak enrichment of CNE+2 compared to the other sites.
We found SCL, E2A (E47) together with LMO2 and Ldb1 at the downstream CNEs and the promoter. Once more, the enrichment of CNE+1 and +3 was higher than the promoter and CNE+2. We also found both subunits of NF-E2 at CNE+3. Human Gfi1b binding and histone modifications were similar to those of mouse (Online supplementary Figure 8B ).
In conclusion, the regulatory mechanisms driven by these distal elements have been preserved in erythroid and megakaryocytic lineages and between human and mouse.
CNE+1 and CNE+3 interact with Gfi1b promoter
If the transcription factor binding elements we have found at Gfi1b locus behave as long-distance cis-regulators, how do they interact with the gene promoter? Chromosome conformation capture or 3C technique can provide evidence of changes in chromosomal structure due to direct long-range interactions, probably through a looping mechanism.
33,34
L929 and MEL cells were formaldehyde cross-linked, the cross-linked chromatin digested with restriction enzyme DpnII and then ligated. Interactions between the Gfi1b promoter and downstream regions were quantified by real time PCR with a primer and a Taqman probe at the Gfi1b promoter and a primer at each downstream fragment. PCR amplification was ligation dependent (data not shown). L929 and MEL cells showed similar enrichment of the promoter with exon 7 and +8802/+9399 PCR products that decreased in relation with the distance to the promoter in a linear conformation. However, analysis of CNE+1 and CNE+3-promoter interactions showed a higher enrichment in MEL cells over L929 that was not distance related ( Figure 6A ), suggesting that these sequences may well interact with the promoter via an erythroid specific looping mechanism. 
Gfi1b is expressed at different level in individual cells
The co-localization of chromatin modifications and some transcription factors related to gene activation were found in association with the binding of Gfi1b protein together with corepressors. These opposing functions may operate at different maturation or cell cycle stages, or could be related to varying Gfi1b concentrations in different cells within the same population. To test this hypothesis we studied Gfi1b protein level by immunofluorescence that distinguishes the protein concentration in individual cells. When uninduced MEL cells were stained with the Gfi1b antibody and studied by confocal microscopy, we observed a high level cell to cell variation in fluorescence intensity, supporting the hypothesis of intercellular heterogeneity ( Figure 6B-C) . A similar degree of heterogeneity was seen in induced MEL cells but with a decrease in Gfi1b intensity with differentiation, in agreement with our previous data ( Figure 6C ).
Discussion
Gfi1b plays a critical role in normal erythropoiesis and megakaryopoiesis [4] [5] [6] and is though to be involved in blood malignancy. 7, 8 The regulation of the Gfi1b gene is largely unknown and the promoter is the only regulatory element identified to date in erythroid and megakaryocytic cells. 17, 18, 22 Here we have identified additional Gfi1b cis-regulatory sequences that have been highly conserved through evolution. One element lies in the first intron of the Gfi1b gene (CNEi) and three lie downstream of the gene (called +1, +2 and +3 according to their proximity to Gfi1b coding sequence). All showed multiple conserved binding sites for erythroid/megakaryocytic transcription factors. Two of these sites (+1 and +3) associate with an open chromatin conformation as determined by the FAIRE assay and DNase1 hypersensitivity and appear to interact with the Gfi1b promoter specifically in expressing cells in the 3C assay. This is the first time such a study has been performed in primary cells at the Gfi1b locus.
The pattern of transcription factor binding to the promoter and the CNEs is clearly complex. GATA1 and SCL had been previously shown to bind to Gfi1b promoter and were associated with gene activation.
18,22,23
We now show that the whole pentameric complex comprised by GATA1, SCL, E2A, LMO2 and Ldb1 binds to both the promoter and the three downstream elements in human and mouse erythroid and megakaryocytic cells. CNE+1 and +3 show a very strong binding of all these factors, while CNE+2 is weakly enriched in ChIP assays. In addition, the most 3´-element binds 12 We confirmed this binding and also found Gfi1b, CoREST and LSD1 at CNE+1, CNE+3 and CNEi. CNE+2 that has no evident Gfi1b, CoREST or LSD1 enrichment, presents a higher level of AcH4 and H3 diMek4 than the neighboring CNEs, showing that there is an inverse correlation between the two events. We have also detected the corepressor ETO2 binding at some of the areas (CNE+1 and +3) where Gfi1b is present. In vitro experiments have indicated that activating complexes of SCL, E2A and GATA1 turn into repressive complexes when associated with ETO2 and Gfi1b. 13, 19, 20 Other elements (CNEi and the Gfi1b promoter) do not show ETO2 binding in MEL cells.
How do we resolve this apparent paradoxical situation in which combinations of activating and repressive complexes apparently reside at the same conserved elements? A clue may come from the striking heterogeneity in Gfi1b protein levels that was observed with immunofluorescence staining of uninduced and induced MEL cells. These populations faithfully recapitulated the decrease in overall Gfi1b levels on induction with a downward shift in mean fluorescence but with a similar degree of variability in protein content from cell to cell.
We suggest the following model as consistent with all our data. As Gfi1b levels rise in the cell it will bind to its own promoter and to the CNEs. This will attract repressor complexes that progressively switch off the gene through a feedback loop as protein levels rise ( Figure  6D ). As Gfi1b levels decline, repression of Gfi1b expression will decrease until a stage is reached at which the activating complexes once more predominate and expression begins again. These fluctuations may be a fine control mechanism to ensure the correct level of the protein either during the cell cycle or during the process of erythroid maturation. As erythroid cells differentiate, a general decrease in transcription factor expression and subsequent lose of binding to these elements, correlates with progressive reduction in Gfi1b expression. In megakaryocytes other mechanisms could be involved in Gfi1b repression including the recruitment of octamerbinding (Oct) transcription factors to the promoter (Human promoter mutations unveil Oct-1 and GATA-1 opposite action on Gfi1b regulation, A Hernández, A Villegas, and E Anguita, under review).
Validation of this hypothetical model will require further functional experiments. It will also be of great interest to determine if any of these sites are targets of mutations leading to human disease. After the level of Gfi1b in the nucleus reaches certain threshold level, it starts to bind to its own locus at regulatory elements like the promoter, CNEi, +1 and +3, together with ETO2 at some positions, and recruits LSD1 and CoREST. This limits its expression until protein degradation allows the activating forces to overthrow the repressive ones and Gfi1b expression increases. Through erythropoiesis the general reduction in transcription factors produces a slow decline in Gfi1b expression. SCL complex: SCL, LMO2 and Ldb1.
